4//SEC Filing
McFarlane Neil F. 4
Accession 0001437749-25-003328
CIK 0001434647other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:37 PM ET
Size
8.4 KB
Accession
0001437749-25-003328
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2025-02-07+225,000→ 225,000 totalExercise: $7.77Exp: 2035-02-06→ Common Stock (225,000 underlying) - Award
Restricted Stock Unit
2025-02-07+112,500→ 112,500 total→ Common Stock (112,500 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on February 7, 2026, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's continued service through such vesting date.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001681098
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:37 PM ET
- Size
- 8.4 KB